Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials

Main Article Content

Rhonda Schreiber
Kaytiana Crane
Juhin Patel

Keywords

acne, tazarotene, clinical trial, efficacy

Abstract

Abstract Not Available